Industry
Qiagen Strengthens Leadership in Personalized Healthcare
Qiagen has signed an agreement for the acquisition of a strategic stake in Alacris Theranostics, a start-up company using novel technologies to develop individualized cancer treatment strategies based upon a patient's genomic profile. More...18 Jan 2011
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Laboratory Software
ArtelWare
Clinical Chemistry System
P780
In Other News
Collaboration to Develop Digital Pathology Image Analysis Technology for Cancer Diagnosis
GE Healthcare Acquires Clarient, a Leader in Molecular Diagnostics
BIT Analytical Expands Clinical Chemistry, Immunology, Molecular Offerings
SLAS Hosts First Annual China Conference and Exhibition
Strategic Partnership Launches Molecular Assay for Breast Cancer
Commercial Laboratory Now Offers Advanced Genomic Services
Most Important Criterion for DNA Sequencer Users is Accuracy
LabCorp Purchases Genzyme's Genetic Testing Business
Thermo Fisher Scientific Expands in Asia-Pacific Markets
JIB 2010 Meeting Focuses Medical Biology Reform
Roche Diagnostics Intends to Form Strategic Partnership with CapitalBio
Genzyme Enters Agreement to Sell Diagnostics Business
Ergon to Acquire Majority Stake in Elitech
GE Healthcare to Acquire Cancer Diagnostics Company
Hybrid Device Scans for Skin Cancer
Revenues from Molecular Cancer Testing Expected to Rise
Roche Strengthens Presence in Point-of-Care Information Management
BD Diagnostics Collaborate With Bruker to Improve Microbial Identification
Use of Molecular Assays for HIAs Growing Rapidly
Samsung Plunges into the Medical Device Market
BioConference Live to Focus on Clinical Diagnostics
Sysmex Signs Agreement with Labcorp for Hematology System
U.S. Navy Purchases Dry-Hematology Analyzers
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.